Marketing-authorisation holder · United Kingdom
Abbvie Ltd
13 medicines in 2 countries, as authorisation holder and manufacturer.
Loading your page…
Loading your page…
Marketing-authorisation holder · United Kingdom
13 medicines in 2 countries, as authorisation holder and manufacturer.
One free account for the Prognia apps: Ward to study, Osler for clinical answers with their sources, and the network to find your colleagues.
Groups are put together by Prognia from the names regulators publish and from company links; they are not an official corporate structure.
Every medicine in the registers under its name, current ones first.
13 medicines
| Medicine | Substance | Country | Status | Authorised |
|---|---|---|---|---|
| Boey | Botulinum toxin | EU (EMA) | pending | |
| Cokiera | EU (EMA) | Refused | ||
| Exviera | Dasabuvir | EU (EMA) | Withdrawn | 2015 |
| EXVIERA 250mg250mg · Compr. film. | Dasabuvir | Romania | unknown | |
| HUMIRA 40mg40mg · Sol. inj. in pen preumplut | Adalimumab | Romania | unknown | |
| HUMIRA 80 mg80mg · Sol. inj. in pen preumplut | Adalimumab | Romania | unknown | |
| KALETRA 200mg/50mg200mg/50mg · Compr. film. | Lopinavir, Ritonavir | Romania | unknown | |
| KALETRA 80mg/ml + 20mg/ml80mg/ml+20mg/ml · Sol. orala | Lopinavir, Ritonavir | Romania | unknown | |
| NORVIR 100mg100mg · Compr. film. | Ritonavir | Romania | unknown | |
| VENCLYXTO 100mg100mg · Compr. film. | Venetoclax | Romania | unknown | |
| VENCLYXTO 10mg10mg · Compr. film. | Venetoclax | Romania | unknown | |
| VENCLYXTO 50mg50mg · Compr. film. | Venetoclax | Romania | unknown | |
| VIEKIRAX 12.5mg/75mg/50mg12.5mg/75mg/50mg · Compr. film. | Ombitasvir, Paritaprevir, Ritonavir | Romania | unknown |
Where it holds or makes medicines, with how many are current.
| Country | Medicines | Current | Past | Companies |
|---|---|---|---|---|
| Romania | 10 | 0 | 10 | CompaniesAll medicines |
| European Union (EMA) | 3 | 0 | 3 | CompaniesAll medicines |
Also in the registers of Brazil, Netherlands, Saudi Arabia, Spain, United Kingdom
The ATC groups most of its medicines belong to, largest first.
The active substances in most of its medicines.
How the registers spell it, normalised: legal forms, accents and capitals removed.
Compiled by Prognia from the public medicine and company registers below. Logos are not used.
Source: European Medicines Agency (EPAR data).
Licence: EMA reuse policy (source acknowledgement required)
Anvisa, official medicine/API manufacturer factual export, HTTP source version Fri, 09 Oct 2026 08:21:54 GMT, acquired 2026-10-09; exact unmodified native identifiers and fields preserved.
Licence: Brazil federal factual open-data reuse; Decreto 8777/2016 consolidated article 4 and third-party exceptions
Fuente de la información: Agencia Española de Medicamentos y Productos Sanitarios www.aemps.gob.es; CIMA presentaciones, acquired 11 October 2026 UTC; each source response/update date retained.
Licence: AEMPS explicit public open-data reuse for citizens and companies; source attribution and update date required
Fuente de la información: Agencia Española de Medicamentos y Productos Sanitarios www.aemps.gob.es; CIMA medicamentos, acquired 11 October 2026 UTC; each source response/update date retained.
Licence: AEMPS explicit public open-data reuse for citizens and companies; source attribution and update date required
Companies House, Find and update company information; exact company number and page URL, accessed 8 October 2026. Structured factual extraction by Prognia. Crown-created website material under OGL 3.0: https://www.nationalarchives.gov.uk/doc/open-government-licence/version/3/.
Licence: Companies House statutory public-register use; OGL 3.0 for Crown-created website material
Medicines and Healthcare products Regulatory Agency (MHRA), GOV.UK; Category 1 list; publication updated 25 August 2026; acquired 2026-10-15T08:18:47.757811+00:00; original workbook cells and factual authorization/holder projections adapted under Open Government Licence v3.0.
Licence: Open Government Licence v3.0; exact Crown copyright 2026 publication grant
Medicines and Healthcare products Regulatory Agency (MHRA), GOV.UK; Category 2 list; publication updated 25 August 2026; acquired 2026-10-15T08:18:48.423930+00:00; original workbook cells and factual authorization/holder projections adapted under Open Government Licence v3.0.
Licence: Open Government Licence v3.0; exact Crown copyright 2026 publication grant
College ter Beoordeling van Geneesmiddelen, Geneesmiddeleninformatiebank metadata, source update 07-10-2026; downloaded 08-10-2026; factual adaptation.
Licence: Conditional noncreative administrative factual metadata; no dataset-wide CC0 claim
Ministerul Sănătății, Catalogul public naţional al preţurilor, 18 iunie 2021, downloaded 2026-10-08 from data.gov.ro; CC BY 4.0; structured factual adaptation, code whitespace trimmed only where explicitly recorded.
Licence: Creative Commons Attribution 4.0 International (CC BY 4.0)
Saudi Food and Drug Authority (SFDA), foreign human medicine open-data listing, source scope 2023, retrieved 11 October 2026 UTC; exact original file and response modification date retained.
Licence: Exact SFDA open-data section explicitly offers freely usable named human medicine workbooks; factual-data scope only
Report an error or request removalCorrections from the company itself are welcome.
Other companies in the same group.
Ranked by their number of medicines.